accounts for about 10% of thyroid cancer with females affected three times as frequently as males and with a peak incidence at 55 years of age
usually unifocal and rarely spreads to lymph nodes. It is angioinvasive to lungs and bone in over 50% of cases and this may be the first sign of malignancy
it is a well differentiated tumour and shows reasonable response to TSH. It may take up iodine and may form thyroid hormones. Very rarely, it produces hyperthyroidism
usually treated with surgery, which can be supplemented with radioiodine ablation. Survival rates are excellent
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.